0000899243-20-000316.txt : 20200103
0000899243-20-000316.hdr.sgml : 20200103
20200103173625
ACCESSION NUMBER: 0000899243-20-000316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TZIANABOS ARTHUR
CENTRAL INDEX KEY: 0001586226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 20507017
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-301-7277
MAIL ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001661998
Homology Medicines, Inc.
FIXX
0001586226
TZIANABOS ARTHUR
C/O HOMOLOGY MEDICINES, INC.
ONE PATRIOTS PARK
BEDFORD
MA
01730
1
1
0
0
President & CEO
Common Stock
2020-01-02
4
S
0
12500
20.4953
D
90005
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018.
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $20.3800 to $20.7000. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Bradford Smith, Attorney-in-Fact for Arthur Tzianabos
2020-01-03